Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00108368 · ClinicalTrials.gov registry record · Phase 4
The Effects of Risperidone and Olanzapine on Thinking
A Phase 4 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 4
- Development phase
NCT00108368: Completed Phase 4 study, sponsored by US Department of Veterans Affairs.
NCT00108368 is a Phase 4 study that has completed, run by US Department of Veterans Affairs. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00108368, a Phase 4 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 4
- Development phase
Study Summary
The goal of this research is to find ways to maximize the benefits of antipsychotic medications for cognition. Hypothesis: Risperidone and olanzapine will show greater benefits than conventional medications on assessments of social cognition, particularly affect perception and social perception.
Interventions
- DRUG Risperidone
- DRUG Olanzapine
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-10 |
| Est. Completion | 2006-03 |
| Phase | Phase 4 |
What the finished NCT00108368 record still lists
NCT00108368 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which Risperidone is the first listed.
NCT00108368 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00108368 about?
NCT00108368 is a clinical study titled "The Effects of Risperidone and Olanzapine on Thinking". The goal of this research is to find ways to maximize the benefits of antipsychotic medications for cognition. Hypothesis: Risperidone and olanzapine will show greater benefits than conventional medications on assessments of social cognition, particularly affect perception and social perception.
What is the current status of trial NCT00108368?
This trial is currently completed. It is a Phase 4 study. The study started on 2003-10. Estimated completion is 2006-03.
What interventions are being tested in trial NCT00108368?
The interventions under investigation include: Risperidone (DRUG), Olanzapine (DRUG).
Who is sponsoring clinical trial NCT00108368?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia